Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.
Wissel J, Bensmail D, Ferreira JJ, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqué B, Simon O, Rochford ET, Dressler D, Simpson DM; TOWER study investigators.
Wissel J, et al. Among authors: simpson dm.
Neurology. 2017 Apr 4;88(14):1321-1328. doi: 10.1212/WNL.0000000000003789. Epub 2017 Mar 10.
Neurology. 2017.
PMID: 28283596
Free PMC article.